Benefits of Preserving Residual Urine Output in Patients Undergoing Maintenance Haemodialysis

References

• Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169. doi:10.1161/01.CIR.0000095676.90936.80
   PubMed Web of Science ®Google Scholar
• Go AS, McCulloch CE. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;10:1.
   Google Scholar
• Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol. 2007;18:2644–2648. doi:10.1681/ASN.2007020220
   PubMed Web of Science ®Google Scholar
• Baber U, Stone GW, Weisz G, et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5:S53–61.
   PubMed Web of Science ®Google Scholar
• Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12:7–11. doi:10.1016/j.kisu.2021.11.003
   PubMed Web of Science ®Google Scholar
• Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol. 2022;18:378–395. doi:10.1038/s41581-022-00542-7
   PubMed Web of Science ®Google Scholar
• Dębska-ślizień A, Jagodziński P, Rutkowski P, et al. Current status of renal replacement therapy in Poland in 2022. NEFROL DIAL POL. 2022;2022:21–38.
   Google Scholar
• Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis. 2001;38:85–90. doi:10.1053/ajkd.2001.25198
   PubMed Web of Science ®Google Scholar
• Brener ZZ, Thijssen S, Kotanko P, et al. The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients. Blood Purif. 2011;31:243–251. doi:10.1159/000322252
   PubMed Web of Science ®Google Scholar
• Obi Y, Rhee CM, Mathew AT, et al. Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol. 2016;27:3758–3768. doi:10.1681/ASN.2015101142
   PubMed Web of Science ®Google Scholar
• Lowenstein J, Grantham JJ. Residual renal function: a paradigm shift. Kidney Int. 2017;91:561–565. doi:10.1016/j.kint.2016.09.052
   PubMed Web of Science ®Google Scholar
• Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–564. doi:10.1681/ASN.V113556
   PubMed Web of Science ®Google Scholar
• Lemes HP, Araujo S, Nascimento D, et al. Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis. Clin Exp Nephrol. 2011;15:554–559. doi:10.1007/s10157-011-0427-z
   PubMed Web of Science ®Google Scholar
• Iwasawa H, Nakao T, Matsumoto H, Okada T, Nagaoka Y, Wada T. Phosphate handling by end-stage kidneys and benefits of residual renal function on phosphate removal in patients on haemodialysis: phosphate handling by RRF in HD patients. Nephrology. 2013;18:285–291. doi:10.1111/nep.12039
   PubMed Web of Science ®Google Scholar
• Milutinovic J, Cutler RE, Hoover P, Meijsen B, Scribner BH. Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int. 1975;8:185–190. doi:10.1038/ki.1975.98
   PubMed Web of Science ®Google Scholar
• Brener ZZ, Kotanko P, Winchester JF, Thijssen S, Bergman M. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians. Am J Med Sci. 2010;339:453–456. doi:10.1097/MAJ.0b013e3181cf7d5b
   PubMed Web of Science ®Google Scholar
• Rădulescu D, Ferechide D, Davila C, Ioan S. The importance of residual renal function in chronic dialysed patients 2. J Med Life. 2009;2(2):199.
   PubMedGoogle Scholar
• Shafi T, Jaar BG, Plantinga LC, et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the choices for healthy outcomes in caring for end-stage renal disease (CHOICE) Study. Am J Kidney Dis. 2010;56:348–358. doi:10.1053/j.ajkd.2010.03.020
   PubMed Web of Science ®Google Scholar
• Wang AY-M, Lai K-N. The importance of residual renal function in dialysis patients. Kidney Int. 2006;69:1726–1732. doi:10.1038/sj.ki.5000382
   PubMed Web of Science ®Google Scholar
• Perl J, Bargman JM. The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis. 2009;53:1068–1081. doi:10.1053/j.ajkd.2009.02.012
   PubMed Web of Science ®Google Scholar
• Fernández-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Pérez J, Quereda-Rodríguez-Navarro C. Mantenimiento de la función renal residual en hemodiálisis: experiencia de 5 años de una pauta de diálisis incremental [Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen]. Nefrología. 2012;32(6):767–776. doi:10.3265/Nefrologia.pre2012.Jul.11517
   PubMed Web of Science ®Google Scholar
• Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renov Dis. 2016;9:319–328. doi:10.2147/IJNRD.S84784
   PubMed Web of Science ®Google Scholar
• Araujo S, Lemes HP, Cunha DA, et al. Cardiac morphology and function in patients with and without residual diuresis on hemodialysis. Brazilian. 2011;8:74–81.
   Google Scholar
• Ma T, Ding G. Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis. Ren Fail. 2013;35:198–203. doi:10.3109/0886022X.2012.745153
   PubMed Web of Science ®Google Scholar
• Artunc F, Mueller C, Breidthardt T, et al. Sensitive troponins – which suits better for hemodialysis patients? Associated factors and prediction of mortality ed W-H schunck. PLoS One. 2012;7:e47610. doi:10.1371/journal.pone.0047610
   PubMed Web of Science ®Google Scholar
• Bragg-Gresham JL, Fissell RB, Mason NA, et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the dialysis outcomes and practice pattern study (DOPPS). Am J Kidney Dis. 2007;49:426–431. doi:10.1053/j.ajkd.2006.12.012
   PubMed Web of Science ®Google Scholar
• Helal I, Belhadj R, Mohseni A, et al. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients. Saudi J Kid Dis Transpl. 2010;21(2):262–268.
   PubMedGoogle Scholar
• Penne EL, van der Weerd NC, Grooteman MPC, et al. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:281–289. doi:10.2215/CJN.04480510
   PubMed Web of Science ®Google Scholar
• de Almeida LLS, Sette LH, Fonseca FLA, da Bezerra LS, Oliveira Júnior FH, Bérgamo RR. Metabolic and volume status evaluation of hemodialysis patients with and without residual renal function in the long interdialytic interval. Braz J Nephrol. 2019;41:481–491. doi:10.1590/2175-8239-jbn-2018-0171
   Google Scholar
• Pizza F, Persici E, La Manna G, et al. Family recurrence and oligo-anuria predict uremic restless legs syndrome: clinical predictors of RLS in hemodialysis patients. Acta Neurol Scand. 2012;125:403–409. doi:10.1111/j.1600-0404.2011.01581.x
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Heimbürger O, Bárány P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003;41:1212–1218. doi:10.1016/S0272-6386(03)00353-6
   PubMed Web of Science ®Google Scholar
• Naskalski JW, Kapusta M, Fedak D, et al. Effect of hemodialysis on acid leukocyte-type ribonuclease, alkaline ribonuclease and polymorphonuclear elastase serum levels in patients with end-stage renal disease. Nephron Clin Pract. 2009;112:c248–54. doi:10.1159/000224791
   PubMedGoogle Scholar
• Borges DL, Lemes HP, de Castro Ferreira V, Filho SRF. High-sensitivity C-reactive protein, apolipoproteins, and residual diuresis in chronic kidney disease patients undergoing hemodialysis. Clin Exp Nephrol. 2016;20:943–950. doi:10.1007/s10157-016-1230-7
   PubMed Web of Science ®Google Scholar
• de Sequera P, Corchete E, Bohorquez L, et al. Residual renal function in hemodialysis and inflammation: RRF in HD and inflammation. Ther Apher Dial. 2017;21:592–598. doi:10.1111/1744-9987.12576
   PubMed Web of Science ®Google Scholar
• Suda T, Hiroshige K, Ohta T, et al. The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant. 2000;15:396–401. doi:10.1093/ndt/15.3.396
   PubMed Web of Science ®Google Scholar
• Nechita AM, Rădulescu D, Peride I, et al. Determining factors of diuresis in chronic kidney disease patients initiating hemodialysis 8. J Med Life. 2015;8(3):371.
   PubMedGoogle Scholar
• Merino JL, Domínguez P, Bueno B, Amézquita Y, Espejo B, Paraíso V. Application of model of incremental haemodialysis, based on residual renal function, at the initiation of renal replacement therapy. Nefrol Engl Ed. 2017;37:39–46.
   PubMed Web of Science ®Google Scholar
• Misra M, Vonesh E, Churchill DN, Moore HL, Van Stone JC, Nolph KD. Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout. Kidney Int. 2000;57:691–696. doi:10.1046/j.1523-1755.2000.00891.x
   PubMed Web of Science ®Google Scholar
• Wang TJ, Tofler GH, Jacques PF, Rifai N, Benjamin EJ, Vasan RS. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631–2639. doi:10.1056/NEJMoa055373
   PubMed Web of Science ®Google Scholar
• Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults. J Am Coll Cardiol. 2008;52:450–459. doi:10.1016/j.jacc.2008.04.033
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503.
   PubMed Web of Science ®Google Scholar
• deFilippi CR, de Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494. doi:10.1001/jama.2010.1708
   PubMed Web of Science ®Google Scholar
• Saunders JT, Nambi V, de Lemos JA, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation. 2011;123:1367–1376. doi:10.1161/CIRCULATIONAHA.110.005264
   PubMed Web of Science ®Google Scholar
• Hecking M, Karaboyas A, Saran R, et al. Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol. 2012;7:92–100. doi:10.2215/CJN.05440611
   PubMed Web of Science ®Google Scholar
• Zbroch E, Koc-Zorawska E, Malyszko J, Malyszko J, Mysliwiec M. Circulating levels of renalase, norepinephrine, and dopamine in dialysis patients. Ren Fail. 2013;35:673–679. doi:10.3109/0886022X.2013.778754
   PubMed Web of Science ®Google Scholar
• Ikizler TA, Hakim RM. Nutrition in end-stage renal disease. Kidney Int. 1996;50:343–357. doi:10.1038/ki.1996.323
   PubMed Web of Science ®Google Scholar
• Raslan M, Gonzalez MC, Gonçalves Dias MC, et al. Comparison of nutritional risk screening tools for predicting clinical outcomes in hospitalized patients. Nutrition. 2010;26:721–726. doi:10.1016/j.nut.2009.07.010
   PubMed Web of Science ®Google Scholar
• McWhirter JP, Pennington CR. Incidence and recognition of malnutrition in hospital. BMJ. 1994;308:945–948. doi:10.1136/bmj.308.6934.945
   PubMed Web of Science ®Google Scholar
• Trimarchi H. Residual urinary output in high body mass index individuals on chronic hemodialysis: a disregarded life vest? World J Nephrol. 2014;3:317. doi:10.5527/wjn.v3.i4.317
   PubMedGoogle Scholar
• Drechsler C, de Mutsert R, Grootendorst DC, et al. Association of body mass index with decline in residual kidney function after initiation of dialysis. Am J Kidney Dis. 2009;53:1014–1023. doi:10.1053/j.ajkd.2008.11.027
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543–554. doi:10.1093/ajcn/81.3.543
   PubMed Web of Science ®Google Scholar